Susan L. Cohn
#81,344
Most Influential Person Now
Professor of pediatrics
Susan L. Cohn's AcademicInfluence.com Rankings
Susan L. Cohnmedical Degrees
Medical
#1505
World Rank
#1849
Historical Rank
Pediatrics
#64
World Rank
#75
Historical Rank
Download Badge
Medical
Susan L. Cohn's Degrees
- Doctorate Medicine University of Chicago
- PhD Biochemistry University of Chicago
Why Is Susan L. Cohn Influential?
(Suggest an Edit or Addition)According to Wikipedia, Susan Lerner Cohn is a professor of pediatrics and section chief of oncology and hematopoietic stem cell transplantation at the Pritzker School of Medicine of the University of Chicago. She is recognized for her contributions to pediatric oncology research.
Susan L. Cohn's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. (2010) (1385)
- The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. (2009) (1201)
- The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. (2009) (765)
- Advances in Risk Classification and Treatment Strategies for Neuroblastoma. (2015) (563)
- Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. (2005) (483)
- Development and validation of a self-completed HIV symptom index. (2001) (370)
- Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. (2011) (352)
- Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. (1996) (340)
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee (2009) (330)
- Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. (1996) (310)
- Chromosome 1p and 11q deletions and outcome in neuroblastoma. (2005) (299)
- Children's Oncology Group's 2013 blueprint for research: Neuroblastoma (2013) (290)
- Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. (2010) (239)
- Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project. (2011) (237)
- Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. (2014) (230)
- Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. (2013) (221)
- Mate Density, Predation Risk, and the Seasonal Sequence of Mate Choices: A Dynamic Game (1991) (217)
- Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study. (2010) (213)
- Advances in the diagnosis and treatment of neuroblastoma (1998) (213)
- Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force (2010) (191)
- Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. (2017) (179)
- Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study. (1998) (173)
- Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma. (2006) (165)
- SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. (2002) (164)
- Gender differences in health-related quality of life in patients with HIV/AIDS (2005) (164)
- Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group (2013) (161)
- Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial. (2019) (160)
- Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. (1997) (151)
- Modulation of matrix remodeling by SPARC in neoplastic progression. (2010) (142)
- Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. (2014) (142)
- TET1-Mediated Hydroxymethylation Facilitates Hypoxic Gene Induction in Neuroblastoma (2014) (141)
- Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project (2012) (141)
- Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro (2005) (141)
- Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. (2005) (140)
- In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. (2015) (139)
- A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants: A Children's Oncology Group Study (2012) (137)
- Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study. (2011) (134)
- Adherence to Antiretrovirals Among US Women During and After Pregnancy (2008) (134)
- Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial. (2019) (130)
- Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study. (2002) (120)
- ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux (2011) (119)
- Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database. (2009) (117)
- Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. (1994) (117)
- Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma. (2003) (116)
- Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force (2009) (116)
- SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix (2006) (111)
- Discontinuation of Mycobacterium avium Complex Prophylaxis in Patients with Antiretroviral TherapyInduced Increases in CD4+ Cell Count (2000) (111)
- Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project. (2011) (110)
- MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN. (2000) (109)
- Methylation of CASP8, DCR2, and HIN-1 in Neuroblastoma Is Associated with Poor Outcome (2007) (109)
- Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study. (2011) (109)
- Contraception and fertility plans in a cohort of HIV-positive women in care. (2007) (108)
- Simplified single patch technique for the repair of atrioventricular septal defect. (1999) (107)
- Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study (2015) (105)
- Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study. (1997) (105)
- The International Neuroblastoma Risk Groups (INRG): a preliminary report. (1997) (104)
- Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study. (2010) (103)
- The MYCN enigma: significance of MYCN expression in neuroblastoma. (2006) (103)
- Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study. (2011) (98)
- Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study. (2000) (98)
- Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. (2003) (98)
- Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group project (2014) (95)
- Association of Epigenetic Inactivation of RASSF1A with Poor Outcome in Human Neuroblastoma (2004) (94)
- Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification. (1990) (93)
- Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. (2000) (93)
- Residential Pesticide Exposure and Neuroblastoma (2001) (91)
- Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. (2000) (91)
- Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. (1995) (90)
- Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641. (2012) (89)
- Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma. (2007) (88)
- Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068. (2006) (87)
- Specialty training and specialization among physicians who treat HIV/AIDS in the United States (2007) (87)
- Depo‐medroxyprogesterone in Women on Antiretroviral Therapy: Effective Contraception and Lack of Clinically Significant Interactions (2007) (85)
- Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital. (2004) (84)
- Feasibility, acceptability, and preliminary efficacy of the unity workshop: an internalized stigma reduction intervention for African American women living with HIV. (2012) (84)
- Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening (1991) (84)
- Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks (2015) (83)
- Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study. (2001) (82)
- Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group (2021) (81)
- HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients (2007) (81)
- Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma. (2004) (81)
- Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience. (2001) (81)
- Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy. (2005) (81)
- MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma (2004) (80)
- Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group (2011) (79)
- High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas. (1999) (77)
- Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257. (2015) (74)
- Physician specialization and antiretroviral therapy for HIV (2003) (72)
- Advances in the diagnosis and treatment of neuroblastoma. (2003) (71)
- The Care of HIV‐Infected Adults in Rural Areas of the United States (2001) (71)
- Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG (2009) (68)
- Preferential amplification of the paternal allele of the N–myc gene in human neuroblastomas (1993) (68)
- The Geography of AIDS: Patterns of Urban and Rural Migration (1994) (68)
- The biological effects of antisense N-myc expression in human neuroblastoma. (1994) (67)
- Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093. (2008) (67)
- Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma. (1999) (66)
- Native valve endocarditis due to Corynebacterium striatum: case report and review. (1994) (65)
- Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362 (2011) (65)
- A phase III randomized clinical trial (RCT) of tandem myeloablative autologous stem cell transplant (ASCT) using peripheral blood stem cell (PBSC) as consolidation therapy for high-risk neuroblastoma (HR-NB): A Children's Oncology Group (COG) study. (2016) (65)
- Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women. (2013) (63)
- Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group. (2008) (63)
- Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. (1999) (63)
- Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden. (1999) (63)
- Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age. (2011) (63)
- Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group (2013) (62)
- Minorities Remain Underrepresented in HIV/AIDS Research Despite Access to Clinical Trials (2014) (61)
- Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma. (1997) (60)
- Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. (1990) (60)
- A Phase 1 Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 7 Days Every 21 Days in Pediatric Patients with Solid Tumors (2006) (59)
- p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease. (2001) (59)
- HuD, a Neuronal-specific RNA-binding Protein, Increases thein Vivo Stability of MYCN RNA* (2002) (59)
- Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project (2008) (59)
- Patient/Family Education for Newly Diagnosed Pediatric Oncology Patients: Consensus Recommendations from a Children’s Oncology Group Expert Panel (2016) (59)
- Long-term outcome of patients with intraspinal neuroblastoma. (1999) (59)
- Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. (1991) (58)
- Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project. (2017) (58)
- Schwann cell-conditioned medium inhibits angiogenesis. (2000) (57)
- Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. (2011) (57)
- Where to seek care: an examination of people in rural areas with HIV/AIDS. (2002) (56)
- Contraceptive Efficacy of Oral and Transdermal Hormones When Co-Administered With Protease Inhibitors in HIV-1-Infected Women: Pharmacokinetic Results of ACTG Trial A5188 (2010) (56)
- MYCN amplification remains prognostically strong 20 years after its "clinical debut". (2004) (56)
- Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma (2015) (55)
- Neuroblastoma Angiogenesis Is Inhibited with a Folded Synthetic Molecule Corresponding to the Epidermal Growth Factor-Like Module of the Follistatin Domain of SPARC (2004) (55)
- Secreted Protein Acidic and Rich in Cysteine Is a Matrix Scavenger Chaperone (2011) (55)
- Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database. (2016) (54)
- Perimenopausal symptomatology among HIV-infected women at least 40 years of age. (2000) (54)
- Co‐amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma (1995) (54)
- Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032 (2021) (53)
- The spectrum of metabolic bone disease in lymphoblastic leukemia (1987) (53)
- Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus. (1991) (53)
- Second malignancies in patients with neuroblastoma: The effects of risk‐based therapy (2015) (52)
- A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High‐Risk Neuroblastoma (2016) (52)
- Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. (2008) (51)
- Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma (2018) (50)
- Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team. (2000) (50)
- SPARC enhances tumor stroma formation and prevents fibroblast activation (2007) (50)
- The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives. (2005) (49)
- Up-regulation of HOXC6, HOXD1, and HOXD8 homeobox gene expression in human neuroblastoma cells following chemical induction of differentiation. (1996) (48)
- Racial differences in care among hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham. (1995) (47)
- Presence Of Cancer-Associated Fibroblasts Inversely Correlates With Schwannian Stroma In Neuroblastoma Tumors (2009) (47)
- Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. (1995) (46)
- High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene. (2007) (46)
- Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation (2016) (46)
- Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors (2010) (46)
- Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531. (2014) (46)
- Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts. (2005) (45)
- Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group (2017) (44)
- Genetic discoveries and treatment advances in neuroblastoma (2016) (44)
- Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects. (2005) (44)
- RNA expression of the WT1 gene in Wilms' tumors in relation to histology. (1992) (43)
- Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population (2013) (43)
- Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN). (2010) (43)
- Loss of DCC expression in neuroblastoma is associated with disease dissemination. (1996) (43)
- Binding of a 40-kDa Protein to the N-myc 3′-Untranslated Region Correlates with Enhanced N-myc Expression in Human Neuroblastoma* (1996) (43)
- Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy (2017) (42)
- Modulation of N-myc expression alters the invasiveness of neuroblastoma (1997) (42)
- Pregnancy Intentions Among Women Living With HIV in the United States (2014) (42)
- Differential Activity of ELAV-like RNA-binding Proteins in Human Neuroblastoma* (1996) (42)
- Parental smoking and alcohol consumption and risk of neuroblastoma. (2000) (42)
- Single copies of the N‐myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus‐myoclonus (1988) (41)
- Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084. (2008) (41)
- Traumatic retrolisthesis of the lumbosacral junction. A case report. (1989) (40)
- Prominent Microvascular Proliferation in Clinically Aggressive Neuroblastoma (2007) (40)
- Secondary malignant neoplasms after high‐dose chemotherapy and autologous stem cell rescue for high‐risk neuroblastoma (2014) (40)
- Methylation-Associated Silencing of the Heat Shock Protein 47 Gene in Human Neuroblastoma (2004) (40)
- Angiogenesis in neuroblastoma. (2000) (39)
- A Pilot Study of Tandem High Dose Chemotherapy with Stem Cell Rescue as Consolidation for High Risk Neuroblastoma: Children’s Oncology Group study ANBL00P1 (2012) (39)
- Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma. (2012) (39)
- N-myc amplification in an infant with stage IVS neuroblastoma. (1987) (38)
- The regulation of angiogenesis in neuroblastoma. (2003) (38)
- HIV-Related Stigma and Viral Suppression Among African-American Women: Exploring the Mediating Roles of Depression and ART Nonadherence (2018) (38)
- Postpartum Viral Load Rebound in HIV-1–Infected Women Treated with Highly Active Antiretroviral Therapy: AIDS Clinical Trials Group Protocol A5150 (2011) (37)
- A rapid preadmission method for predicting inpatient course of disease for patients with HIV-related Pneumocystis carinii pneumonia. (1994) (37)
- The challenge of defining “ultra‐high‐risk” neuroblastoma (2018) (37)
- Diagnosis and classification of the small round-cell tumors of childhood. (1999) (37)
- Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival. (2012) (36)
- Prenatal detection of neuroblastoma by fetal ultrasonography. (1994) (35)
- Significance of clinical and biologic features in Stage 3 neuroblastoma: A report from the International Neuroblastoma Risk Group project (2014) (34)
- Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study (2006) (34)
- Age-Dependent Prognostic Effect by Mitosis-Karyorrhexis Index in Neuroblastoma: A Report from the Children's Oncology Group (2014) (34)
- Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time. (2013) (34)
- Validation of a prognostic multi‐gene signature in high‐risk neuroblastoma using the high throughput digital NanoString nCounter™ system (2014) (34)
- Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants. (2015) (34)
- Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project. (2020) (34)
- Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma. (2000) (33)
- Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531. (2019) (33)
- Increased mtDNA Levels Without Change in Mitochondrial Enzymes in Peripheral Blood Mononuclear Cells of Infants Born to HIV-Infected Mothers on Antiretroviral Therapy (2008) (33)
- A Phase I Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 21 Days Every 28 Days in Pediatric Patients with Solid Tumors (2008) (33)
- Synergism between occupational arsenic exposure and smoking in the induction of lung cancer. (1992) (32)
- Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma (2012) (32)
- Trends of and factors associated with live‐birth and abortion rates among HIV‐positive and HIV‐negative women (2017) (32)
- Positive association between congenital anomalies and risk of neuroblastoma (2005) (31)
- Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy. (2004) (31)
- Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients (2016) (31)
- Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial (2017) (30)
- Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database. (2014) (30)
- 'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis. (2005) (29)
- Sexually transmitted diseases, HIV, and AIDS in women. (2003) (29)
- The role of the multidrug resistance-associated protein 1 gene in neuroblastoma biology and clinical outcome. (2005) (29)
- Response and toxicity to a dose-intensive multi-agent chemotherapy induction regimen for high risk neuroblastoma (HR-NB): A Children's Oncology Group (COG A3973) study (2007) (28)
- HIV stigma and viral load among African-American women receiving treatment for HIV. (2019) (28)
- Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines (2010) (27)
- New aspects of neuroblastoma treatment: ASPHO 2011 symposium review (2012) (27)
- Neighborhood community characteristics associated with HIV disease outcomes in a cohort of urban women living with HIV (2016) (27)
- Peripheral neuroblastic tumors with genotype–phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee (2013) (27)
- Activity of a 40 kDa RNA-binding protein correlates with MYCN and c-fos mRNA stability in human neuroblastoma. (1997) (26)
- MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group (2017) (26)
- Emerging and investigational therapies for neuroblastoma (2017) (26)
- Idiopathic genital ulcers in women infected with human immunodeficiency virus. (1996) (25)
- Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome. (2002) (24)
- Vascular problems of the lower extremity in athletes. (1990) (24)
- Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth (2012) (24)
- Detection of hydrogen peroxide-producing Lactobacillus species in the vagina: a comparison of culture and quantitative PCR among HIV-1 seropositive women (2012) (24)
- Natural killer cell lymphoma (2001) (23)
- Rituximab for treatment of opsoclonus‐myoclonus syndrome in neuroblastoma (2008) (23)
- Assessing Stigma among African Americans Living with HIV. (2016) (23)
- Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial. (2015) (23)
- Empirically treated Pneumocystis carinii pneumonia in Los Angeles, Chicago, and Miami: 1987-1990. (1995) (23)
- Clinical outcome in children with recurrent neuroblastoma treated with ABT‐751 and effect of ABT‐751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro (2010) (23)
- Lupus-like nephritis in an HIV-positive patient: report of a case and review of the literature. (2003) (22)
- Unrealistic parental expectations for cure in poor‐prognosis childhood cancer (2020) (22)
- Pertussus Is Rare in Human Immunodeficiency Virus Disease (1993) (22)
- Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant (2014) (22)
- Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma. (2017) (22)
- Stigma Reduction Among African American Women With HIV: UNITY Health Study (2018) (21)
- Depot Medroxyprogesterone Acetate in Combination with a Twice-Daily Lopinavir-Ritonavir-Based Regimen in HIV-Infected Women Showed Effective Contraception and a Lack of Clinically Significant Interactions, with Good Safety and Tolerability: Results of the ACTG 5283 Study (2015) (21)
- Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors. (2005) (21)
- Present status of serum tumor markers in diagnosis, prognosis, and evaluation of therapy. (1986) (21)
- Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma. (1998) (21)
- A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high‐risk neuroblastoma: An International Neuroblastoma Risk Group project (2020) (20)
- Collection, storage, and infusion of stem cells in children with high‐risk neuroblastoma: Saving for a rainy day (2006) (20)
- Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy (2016) (20)
- Disparities in Care for HIV Patients (2006) (20)
- A topotecan-containing induction regimen for treatment of high risk neuroblastoma. (2006) (19)
- Using Germline Genomics to Individualize Pediatric Cancer Treatments (2012) (19)
- Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies. (2009) (19)
- Quality-of-Care Indicators for HIV/AIDS (2000) (19)
- 5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma (2019) (19)
- Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System. (2018) (19)
- Racial and Ethnic Differences in Communication and Care for Children with Advanced Cancer. (2020) (18)
- Excellent local tumor control regardless of extent of surgical resection after treatment on the Chicago Pilot II protocol for neuroblastoma. (2006) (18)
- Progress in defining and treating high-risk neuroblastoma: lessons from the bench and bedside. (2009) (18)
- Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States (2019) (18)
- The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project (2020) (18)
- Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT‐751: A report from the Children's Oncology Group (ANBL0621) (2014) (18)
- A randomized phase III trial of myeloablative autologous peripheral blood stem cell (PBSC) transplant (ASCT) for high-risk neuroblastoma (HR-NB) employing immunomagnetic purged (P) versus unpurged (UP) PBSC: A Children’s Oncology Group study (2008) (18)
- Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines. (1999) (18)
- Opsoclonus‐myoclonus and anti‐Hu positive limbic encephalitis in a patient with neuroblastoma (2012) (18)
- Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors (2009) (18)
- The quinoxaline anti‐tumor agent (R+)XK469 inhibits neuroblastoma tumor growth (2011) (17)
- Antiangiogenic therapy inhibits human neuroblastoma growth. (2001) (17)
- Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma (2019) (17)
- Management of tumor lysis syndrome: need for evidence-based guidelines. (2008) (17)
- Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future. (2020) (17)
- Data Commons to Support Pediatric Cancer Research. (2017) (17)
- Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1A Randomized, Controlled Equivalence TrialNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1 (2014) (17)
- Physical mapping of the DDX1 gene to 340 kb 5' of MYCN. (1996) (16)
- Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse (2016) (16)
- Evidence for molecular heterogeneity in human ganglioneuroblastoma. (1993) (15)
- Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project. (2012) (15)
- HIV stigma and viral load among African-American women receiving treatment for HIV: A longitudinal analysis. (2019) (15)
- Hox gene expression in differentiating human neuroblastoma cells. (1993) (15)
- International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions. (2004) (15)
- School-Based Practice (2007) (15)
- Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin‐Fixed Paraffin‐Embedded Tissue Samples and Are Associated With Recurrence (2016) (15)
- Intraspinal Wilms' tumor metastases (1994) (14)
- Pertussis is rare in human immunodeficiency virus disease. (1993) (14)
- Regional Variation in HIV Clinical Trials Participation in the United States (2015) (14)
- Predictors of resource utilization for hospitalized patients with Pneumocystis carinii pneumonia (PCP): a summary of effects from the multi-city study of quality of PCP care. (1996) (14)
- 5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype (2019) (14)
- Prevention of perinatal transmission of human immunodeficiency virus. (2014) (12)
- Associations Between Genital Tract Infections, Genital Tract Inflammation, and Cervical Cytobrush HIV-1 DNA in US Versus Kenyan Women (2013) (12)
- Religiosity, Social Support, and Ethnic Identity: Exploring “Resilience Resources” for African-American Women Experiencing HIV-Related Stigma (2019) (12)
- Geographic variation in the management and outcome of patients with AIDS-related Pneumocystis carinii pneumonia. (1996) (12)
- Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium (2021) (12)
- Phase 1/2 KEYNOTE-051 study of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1+ advanced, relapsed, or refractory solid tumor or lymphoma. (2017) (12)
- Moderating Factors in an Anti-stigma Intervention for African American Women with HIV in the United States: A Secondary Analysis of the UNITY Trial (2019) (12)
- Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma (2021) (12)
- KEYNOTE-051: An update on the phase 2 results of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1–positive advanced, relapsed or refractory solid tumor or lymphoma. (2018) (12)
- Parenting Desires Among Individuals Living With Human Immunodeficiency Virus in the United States (2018) (12)
- Analysis of possible abnormal WT1 RNA processing in primary Wilms tumors (1996) (11)
- Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids (2016) (11)
- Diagnostic and Therapeutic Advances in Pediatric Oncology (1997) (11)
- Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251 (2016) (10)
- Home Birth in the Era of COVID-19: Counseling and Preparation for Pregnant Persons Living with HIV (2020) (10)
- Low rate of sex-specific analyses in presentations at the Conference of Retroviruses and Opportunistic Infections (CROI) meeting, 2018: Room to improve. (2019) (10)
- Gender Differences in Early Suspicion of Tuberculosis in Hospitalized High-Risk Patients During 4 Epidemic Years, 1987 to 1990 (1997) (10)
- Luteoma of pregnancy. A pseudotumor. (1967) (10)
- 3 + 3 ≠ (Rolling) 6 (2008) (10)
- Immune Reconstitution Following Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma at the Time of Immunotherapy. (2017) (9)
- Integrating Cell-Based and Clinical Genome-Wide Studies to Identify Genetic Variants Contributing to Treatment Failure in Neuroblastoma Patients (2014) (9)
- Lipids and Lactate in Human Immunodeficiency Virus-1–Infected Pregnancies With or Without Protease Inhibitor-Based Therapy (2007) (9)
- Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study. (2019) (9)
- Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology (2017) (9)
- Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals. (2016) (9)
- Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research. (2021) (9)
- Short communication: risk of elevated total cholesterol/high-density lipoprotein cholesterol ratio after antiretroviral therapy in HIV/hepatitis C virus patients. (2012) (8)
- Role of the extent of prophylactic regional lymph node radiotherapy on survival in high‐risk neuroblastoma: A report from the COG A3973 study (2019) (8)
- HIV-1 Shedding From the Female Genital Tract is Associated With Increased Th1 Cytokines/Chemokines That Maintain Tissue Homeostasis and Proportions of CD8+FOXP3+ T Cells (2014) (8)
- Synergy between 5′ and 3′ flanking regions of the human tyrosine hydroxylase gene ensures specific, high-level expression in neuroblastoma cells (2000) (8)
- Patterns of alcohol use and associated characteristics and HIV-related outcomes among a sample of African-American women living with HIV. (2019) (8)
- Repeat pregnancies among HIV-infected women enrolled in clinical trial PACTG1022. (2009) (8)
- Ending the evidence gap for pregnancy, HIV and co‐infections: ethics guidance from the PHASES project (2021) (8)
- Miscarriage among women in the United States Women's Interagency HIV Study, 1994-2017. (2019) (8)
- Skin Test Reactivity and Cellular Immune Responses toMycobacterium avium Sensitin in AIDS Patients at Risk for Disseminated M. avium Infection (2001) (7)
- HIV related vasculitic mononeuropathy multiplex: A role for IVIg? (1997) (7)
- Age, tumor grade, and mitosis-karyorrhexis index (MKI) are independently predictive of outcome in neuroblastoma (NB) (2007) (7)
- AIDS in rural America. (1997) (7)
- Gastrointestinal relapse of leukemia, mimicking acute graft vs. host disease, following a stem cell transplant. (2000) (7)
- Schwann cell-conditioned medium inhibits angiogenesis in vitro and in vivo. (2000) (7)
- Fractures about the knee in sports. (1990) (7)
- HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States (2016) (6)
- A phase III trial of biologically-based therapy reduction for intermediate risk neuroblastoma (2007) (6)
- High levels of N-myc protein in a neuroblastoma cell line lacking N-myc amplification. (1991) (6)
- Data Commons to Support Pediatric Cancer Research. (2017) (6)
- Treatment of two cases with refractory, metastatic intermediate‐risk neuroblastoma with isotretenoin alone or observation (2014) (6)
- Genetically InFormed Therapies—A “GIFT” for Children with Cancer (2012) (6)
- Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women (2016) (6)
- Prevalence of Hepatitis B Virus Infection in Pregnant Women Living with and without HIV in Jos, Nigeria. (2020) (6)
- Risk and protective factors of posttraumatic stress disorder among African American women living with HIV (2018) (5)
- Infantile Myelofibrosis with Nephromegaly Secondary to Myeloid Metaplasia (1991) (5)
- Cord Blood Lipids in Infants Born to HIV-1-Infected Women Treated with Combination Antiretroviral Therapy (2008) (5)
- Stem Cell Transplant‐Associated Wernicke Encephalopathy in a Patient with High‐Risk Neuroblastoma (2015) (5)
- Age Differences by Sex in Antiretroviral‐Naïve Participants: Pooled Analysis from Randomized Clinical Trials (2018) (5)
- Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives (2020) (5)
- Women with HIV/AIDS: treating the fastest-growing population. (2003) (5)
- Rebound thymic hyperplasia following high dose chemotherapy and stem cell transplant in three neuroblastoma patients (2017) (5)
- Women in HIV trials: improving adherence and outcomes. (2017) (5)
- Update on the development of the international neuroblastoma risk group (INRG) classification schema (2007) (5)
- Phase I trial of oral ABT-751 in pediatric patients: Preliminary evidence of activity in neuroblastoma (NBL) (2005) (5)
- Increased T-cell colony formation in AIDS patients treated with zidovudine: a possible mechanism for increased lymphocyte number. (1989) (5)
- Enacted HIV-Related Stigma and Breast-Health Beliefs and Practices Among African American Women Living With HIV: The Mediating Roles of Internalized HIV-Related Stigma and Depressive Symptoms (2017) (4)
- Are molecular neuroblastoma classifiers ready for prime time? (2009) (4)
- Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma (2021) (4)
- Racial and ethnic disparities in disease presentation and survival among children with neuroblastoma (NBL): A Children's Oncology Group (COG) study. (2010) (4)
- Prevalence of Hepatitis B Virus Infection among Pregnant Women in Jos, Nigeria (2020) (4)
- Exploring HIV-Related Stigma as a Determinant of Engagement in HIV Care by African American Women. (2019) (4)
- Surveillance of Childhood Cancer Survivors: A Lifelong Affair. (2015) (4)
- Computer‐assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma (2018) (4)
- Multifocal Staphylococcus aureus infection originating from the sacroiliac joint in a patient with rheumatoid arthritis. (2001) (4)
- An evaluation of norethindrone 2 mg. with mestranol 0.1 mg. in control of conception. (1966) (4)
- A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug–Drug Interactions With Antiretroviral and Antituberculosis Treatment (2021) (3)
- Analysis of possible WT1 RNA processing in primary Wilms tumors. (1996) (3)
- Clinical and biological features predictive of survival after relapse of neuroblastoma: A study from the International Neuroblastoma (NB) Risk Group (INRG) Database. (2010) (3)
- Secreted protein acidic and rich in cysteine (2019) (3)
- Outcomes of a Career Development Program for Underrepresented Minority Investigators in the AIDS Clinical Trials Group (2019) (3)
- Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234). (2015) (3)
- Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group (2020) (3)
- 3 + 3 not equal to (Rolling) 6. (2008) (3)
- Primary ovarian pregnancy. (1967) (3)
- Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification. (1994) (3)
- Association between end‐induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high‐risk neuroblastoma patients (2020) (3)
- PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150. (2015) (3)
- Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease (2022) (3)
- Prognostic markers for stage 3 neuroblastoma (NB): A report from the International Neuroblastoma Risk Group (INRG) project (2008) (3)
- Novel Criteria for Diagnosing Acute and Early HIV Infection in a Multi-National Study of Early Antiretroviral Therapy Initiation. (2020) (3)
- Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression (2013) (3)
- A neuroblastoma risk classification model for developing countries: A study from the International Neuroblastoma (NB) Risk Group (INRG) database. (2014) (3)
- Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate (DMPA) in African women receiving treatment for HIV and TB: Potential concern for standard dosing frequency. (2020) (3)
- Expression of the putative tumour suppressor gene, p73, in neuroblastoma and other childhood tumours. (2001) (2)
- High-Level Expression of EPHB 6 , EFNB 2 , and EFNB 3 Is Associated with Low Tumor Stage and High TrkA Expression in Human Neuroblastomas 1 (1999) (2)
- School-based practice: physical therapists collaborating with physical education teachers. Give it a try! (2007) (2)
- Advances in the treatment of neuroblastoma. (2011) (2)
- Randomized phase II trial of MIBG versus MIBG/vincristine/irinotecan versus MIBG/vorinostat for relapsed/refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy Consortium. (2020) (2)
- Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression. (2019) (2)
- Molecular and Cellular Pathobiology Truncated DNMT 3 B Isoform DNMT 3 B 7 Suppresses Growth , Induces Differentiation , and Alters DNA Methylation in Human Neuroblastoma (2012) (2)
- Contraception methods used among women with HIV starting antiretroviral therapy in a large United States clinical trial, 2009-2011. (2020) (2)
- The pharmacokinetics (PK) and pharmacodynamics (PD) of ABT-751 in children with recurrent neuroblastoma or other solid tumors (2007) (2)
- Disk space infection versus lumbar Scheuermann's disease. (1988) (2)
- International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
- The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab Therapy (2017) (2)
- Megadose Methylprednisolone for the Treatment of Myelofibrosis (1992) (2)
- Stage 4S Neuroblastoma (2020) (2)
- Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients (2003) (1)
- Expression of the multidrug transporter genes ABCC1/MRP1, ABCC3/MRP3, and ABCC4/MRP4 are powerful predictors of clinical outcome in childhood neuroblastoma (2007) (1)
- Development of an open-source, flexible framework for complex inter-institutional disparate data sharing and collaboration. (2013) (1)
- The Experience of Children With Neuroblastoma and Their Parents During Single-Room Isolation for 131I-Metaiodobenzylguanidine Therapy: A Qualitative Descriptive Study (2022) (1)
- Neuroblastoma: solving a biologic puzzle. (1997) (1)
- Progression‐free survival of two cases of high‐risk neuroblastoma with refractory/relapsed disease following surgery alone (2013) (1)
- Potential risk of drug–drug interactions with hormonal contraceptives and antiretrovirals: prevalence in women living with HIV (2020) (1)
- Rethinking high‐risk neuroblastoma treatment (2022) (1)
- Abstract 954: ABCC/MRP multidrug transporters contribute to neuroblastoma biology, pathogenesis and clinical outcome, independently of any role in cytotoxic drug efflux (2011) (1)
- Late morbidity and mortality among survivors of neuroblastoma treated with contemporary therapy: A report from the Childhood Cancer Survivor Study. (2021) (1)
- Consensus statement from the American Cancer Society Workshop on neuroblastoma screening: Do benifit from mass screening for neuroblastoma? (1991) (1)
- Where to Seek Care (2002) (1)
- The future starts here! (2006) (1)
- Response of patients with myelofibrosis to megadose methylprednisolone. (1991) (1)
- Treatment Responses in Antiretroviral Treatment (ART) Naïve Pre-and Post-menopausal HIV-infected Women: An Analysis from ACTG Studies (2009) (1)
- Fertility and contraception among HIV-positive women. (2005) (1)
- MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia (2022) (1)
- Retinoic acid induced expression of homeobox genes in human neuroblastoma cells. (1994) (1)
- Immune System Profiling Following Autologous Stem Cell Transplant for High-Risk Neuroblastoma Reveals Poor Immune Reconstitution at the Start of Immunotherapy That Predicts Disease-Free Survival (2017) (1)
- Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens. (2023) (1)
- Issues Regarding Use of Hormonal Contraceptives in Clinical Trials of Antiretroviral Therapy (2005) (1)
- 128 – Human Immunodeficiency Virus Infection in Women (2015) (1)
- Age-dependency of the prognostic impact of tumor genomics in localized resectable MYCN non-amplified neuroblastomas Report from the SIOPEN Biology Group on the LNESG Trials (2018) (1)
- Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group (2022) (1)
- A Selfless Act. (2015) (1)
- Computer-assisted Curie scoring for metaiodobenzylguanidine (mIBG) scans in patients with neuroblastoma. (2016) (1)
- Reply to Phillips (2005) (1)
- Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group. (2021) (1)
- Irinotecan plus temozolomide in children with recurrent or refractory neuroblastoma: A phase II Children's Oncology Group study. (2009) (1)
- Erratum to: Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma (2013) (1)
- Efavirenz — but not nevirapine — based antiretroviral therapy significantly reduces etonogestrel concentrations among HIV-positive women using subdermal contraceptive implants (2016) (1)
- Impact of dedicated women’s outreach workers (WOWs) on recruitment of women in ACTG clinical studies (2021) (1)
- Measurement of Neighborhood Context in an Urban Cohort of HIV-Infected or at Risk Low-Income Women (2017) (1)
- Long term morbidity and mortality among survivors of infant neuroblastoma: A report from the Childhood Cancer Survivor Study (CCSS). (2019) (1)
- Neuroblastoma Survivors are at Increased Risk for Second Malignancies: A the International Neuroblastoma Risk Group Project (2017) (0)
- Risk-based Treatment for Children with Neuroblastoma (2005) (0)
- Study of ABT-751 , an Orally BioavailableTubulin Inhibitor , Administered Daily for 21 Days Every 28 Days in Pediatric Patients with SolidTumors (2008) (0)
- Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study (2022) (0)
- Immunogenomic determinants of tumor microenvironment correlate with survival in high-risk neuroblastoma (2021) (0)
- Internalized HIV-Related Stigma and Breast Health Beliefs Among African–American Women Receiving Care for HIV in the USA (2020) (0)
- Significance of tumor biology compared to metastatic pattern (INSS 4 versus 4s) and age for prognosis of neuroblastoma less than 18 months of age. (2016) (0)
- Advances in Brief Schwann Cell-conditioned Medium Inhibits Angiogenesis 1 (2000) (0)
- Suppression of malignant phenotype of human neuroblastoma by thrombospondin-1 peptide in combination with valproic acid (2006) (0)
- Treatment a nd O utcome o f 8 3 C hildren W ith I ntraspinal Neuroblastoma: T he P ediatric O ncology G roup E xperience (2001) (0)
- Pediatric Granular Cell Tumors: Clinicopathologic and Molecular Analysis of Six Cases Including Multicentric, Atypical, Malignant, and Non-Neural Tumors (2020) (0)
- Abstract 1040: A truncated DNMT3B protein (DNMT3B7) drives DNA methylation and suppresses growth in human neuroblastoma (2012) (0)
- Predicting response to chemotherapy in neuroblastoma using deep learning: A report from the International Neuroblastoma Risk Group. (2021) (0)
- Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification. (2023) (0)
- Abstract PR16: Whole-genome analysis of the epigenetic mark 5-hydroxymethylcytosine reveals differential profiles in low- , intermediate- , and high-risk neuroblastomas (2018) (0)
- Survival of patients with neuroblastoma before versus after reduction of therapy due to the change in age cut-off from 12 to 18 months in Children’s Oncology Group (COG) risk stratification. (2022) (0)
- Outcome analysis of non-high-risk neuroblastoma patients enrolled on Children’s Oncology Group trials P9641 and A3961. (2012) (0)
- Analysis ofDNAPloidy andProliferative Activity inRelation toHistology andN-myc Amplification inNeuroblastoma (1990) (0)
- A Community Call to Action to Prioritize Inclusion and Enrollment of Women in HIV Cure-related Research (2022) (0)
- Prominent vascular endothelial proliferation in clinically aggressive neuroblastoma (2007) (0)
- Multimodality treatment for recurrent neuroblastoma in the central nervous system (2023) (0)
- Abstract 2486: African ancestry is associated with high-risk disease and event-free survival in children with neuroblastoma (2012) (0)
- Two-drug HIV regimens: more data still needed. (2021) (0)
- Genomic evaluation of a case of Lacticaseibacillus rhamnosus endocarditis: comparison with commercial yogurt isolates and examination of global population structure (2022) (0)
- International consensus for neuroblastoma molecular diagnostics: Report from the international neuroblastoma risk grouping (INRG) Biology committee (2009) (0)
- Clinical Notes (1991) (0)
- Request for INRG Data Analysis Proposal Title : Identifying neuroblastoma drivers and bringing them to the clinic Principle Investigators : (2020) (0)
- Perspectives and Future Directions (2005) (0)
- International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
- MYCN Expression I s N ot P rognostic o f A dverse O utcome i n Advanced-Stage N euroblastoma W ith N onamplified MYCN (2000) (0)
- Abstract A025: Assessing the role of bivalency in MYCN-amplified neuroblastoma (2022) (0)
- 393 POSTER The multidrug transporter MRP4/ABCC4 is a powerful marker of poor prognosis in neuroblastoma and a target for therapeutic suppression (2006) (0)
- Abstract A37: Immunohistochemical detection of MYCN protein and MYC protein identifies highly aggressive neuroblastomas (2015) (0)
- SPARC enhances formation and prevents activation of tumor stroma (2006) (0)
- Relationship of divergent ancestral genetic variation on chromosome 6p22 and racial disparities in survival in neuroblastoma. (2012) (0)
- Abstract B40: MYCN/MYC protein expression in high-MKI (Mitosis-Karyorrhexis Index) neuroblastomas: A report from the Children's Oncology Group (2014) (0)
- Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient (2020) (0)
- Second malignancies in neuroblastoma patients: A report from the International Neuroblastoma Risk Group. (2015) (0)
- 673 Vascular endothelial growth factor expression in neuroblastoma cell lines correlates with tumor phenotype (1996) (0)
- Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study. (2023) (0)
- Locoregional MYCN‐amplified neuroblastoma (2012) (0)
- Hand-Schuller-Christian disease and pregnancy. (1966) (0)
- Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis (2021) (0)
- Immune System Profiling Following Autologous Stem Cell Transplant for High-Risk Neuroblastoma Predicts Disease-Free Survival (2016) (0)
- Development of an open-source, flexible framework for interinstitutional data sharing and collaboration. (2012) (0)
- SNP Array Analysis Detects Genomic Alterations Associated with High-Risk Disease in Neuroblastoma (2012) (0)
- Abstract 3109: Myc confers aggressive medulloblastoma phenotypes by regulating cell migration and adhesion genes (2010) (0)
- Racial and ethnic disparities in risk and survival in children with neuroblastoma: An updated analysis. (2021) (0)
- Abstract A46: Genomic ancestry is associated with risk group and survival in children with neuroblastoma (2011) (0)
- Abstract B02: 5-Hydroxymethylcytosine profiles in circulating cell-free DNA are biomarkers of disease burden in children with neuroblastoma (2020) (0)
- Second malignancies in patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project. (2016) (0)
- Abstract A01: Evaluation of hypoxia adaptation in neuroblastoma identifies reproducible transcriptional and phenotypic responses (2016) (0)
- Interview-Based Conclusions About Rural Versus Urban HIV Care: Questions About the Questions: Reply to “Interview-Based Conclusions About Rural Versus Urban HIV Care: Questions About the Questions” by Hoadley et al.: Reply (2002) (0)
- Neuroblastoma Update: Prognostic Factors (1988) (0)
- A Phase 1Study of ABT-751, an Orally BioavailableTubulin Inhibitor, Administered Daily for 7 Days Every 21Days in Pediatric Patients with Solid Tumors (2006) (0)
- Interactions between antiretroviral therapy and vaginally administered contraceptive hormones: A three–arm, pharmacokinetic evaluation (2019) (0)
- Prevalence of Drug–Drug Interactions with Hormonal Contraceptives and Antiretrovirals in Women Living with HIV (2017) (0)
- Abstract 3607: Modulation of neuroblastoma metabolism by an extracellular chaperone SPARC (2014) (0)
- Reply to K. Beiske et al. (2020) (0)
- Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1. (2014) (0)
- Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032. (2020) (0)
- Abstract A2-55: Identification of evolutionarily conserved hypoxia-induced genomic pathways responsible for aggressive neuroblastoma phenotypes (2015) (0)
- A revised Children's Oncology Group (COG) neuroblastoma risk classification system: Report from the COG biology study ANBL00B1. (2019) (0)
- Uterine rupture in labor following repair for cervical incompetence. (1966) (0)
- Multiple Segmental Chromosomal Aberrations in Low-Risk Neuroblastoma are Associated with Metastatic Relapse (2014) (0)
- Genome-based outcome prediction in MYCN nonamplified high-risk neuroblastoma. (2012) (0)
- Does MYCN AmplificationManifested as Homogeneously Staining Regions at Diagnosis Predict aWorse Outcome in Childrenwith Neuroblastoma ? AChildren ’ s Oncology Group Study (2006) (0)
- Genetic Marker for Clinically Aggressive Neuroblastoma (2008) (0)
- ResearchSPARC peptides inhibit progression of neuroblastoma tumors (2010) (0)
- Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome in Women. (2003) (0)
- Outcome in patients with refractory high-risk neuroblastoma. (2020) (0)
This paper list is powered by the following services:
Other Resources About Susan L. Cohn
What Schools Are Affiliated With Susan L. Cohn?
Susan L. Cohn is affiliated with the following schools:
